Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CareNexa, operating as Molecular Testing Labs (MTL), is a pioneering health science and molecular diagnostics company based in Vancouver, Washington. The company specializes in high-complexity, high-throughput laboratory testing and decentralized diagnostic solutions, including proprietary at-home specimen collection kits for infectious diseases, toxicology, and hormone health. CareNexa's mission is to democratize access to healthcare by removing geographic, financial, and stigma-related barriers to testing through innovative R&D and advanced logistics. Their integrated digital health platform enables telehealth providers, public health agencies, and clinical researchers to deploy scalable, patient-centered diagnostic programs. Through strategic partnerships with organizations like Matrix Medical Network and Tia Health, CareNexa continues to expand its reach in precision medicine and health equity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CareNexa.